ClinicalTrials.govpublic full text
Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia
beta-thalassemia, ace-536, luspatercept, pharmacokinetics, red blood cell transfusion, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 854646
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.